RT Journal Article SR Electronic T1 Review: infliximab increases response and remission rates in fistulising or treatment-resistant Crohn’s disease JF Evidence Based Medicine JO Evid Based Med FD BMJ Publishing Group Ltd SP 186 OP 186 DO 10.1136/ebm.7.6.186 VO 7 IS 6 YR 2002 UL http://ebm.bmj.com/content/7/6/186.abstract AB